Brief: Kindstar Globalgene Technology Sees Profit Attributable For 1H2022 In Range Of RMB60 Mln To RMB68 Mln
01/08/2022 12:52
Aug 1 (Reuters) - Kindstar Globalgene Technology 9960.HK :
* SEES PROFIT ATTRIBUTABLE FOR 1H2022 IS EXPECTED TO BE
WITHIN
RANGE OF RMB 60 MILLION TO RMB 68 MILLION
Further company coverage: 9960.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kindstar Globalgene Technology
See all newsChina's Kindstar Globalgene H1 loss narrows after oncology testing expansion
Brief: Kindstar Globalgene Technology Posts Full-Year Loss Attributable Of RMB58.7 Million
Brief: Kindstar Globalgene Technology Inc Unit To Buy 40% Of Huaxi Kindstar
Brief: Kindstar Globalgene Technology Expects HY Net Loss Of RMB30-35 Million
Brief: Kindstar Globalgene Technology Sees FY Loss Between RMB55 Million And RMB65 Million